NCT06395402
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States
Clinical trial condition
Neuroendocrine Tumor Grade 1
Explore clinical trials studying Neuroendocrine Tumor Grade 1. Study availability and eligibility vary by location and protocol.
7 public trials
5 recruiting studies
Neuroendocrine Tumor Grade 1 trial results
NCT04520932
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +11 more
- Locations
-
- Institut Paoli Calmettes Marseille, France
NCT04464122
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
- Locations
-
- Andrea M Isidori Rome, Italy
NCT06855095
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
- Locations
-
- Antoni van Leeuwenhoek Amsterdam, Netherlands
NCT06472388
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +26 more
- Locations
-
- AC Camargo Cancer Center São Paulo, Brazil
- AC Camargo Cancer Center São Paulo, Brazil
Active, Not Recruiting
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
NCT06148636
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +21 more
- Locations
-
- Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States
Active, Not Recruiting
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
NCT05111509
- Conditions
- Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2
- Locations
-
- The University of Iowa Iowa City, Iowa, United States